Added to YB: 2025-11-12
Pitch date: 2025-11-06
TEVA [bullish]
Teva Pharmaceutical Industries Limited
+23.55%
current return
Author Info
Kontra Investment Xchange is trying to build wealth by investing in good companies and letting those investments compound over many years. Sign up for the newsletter.
Company Info
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
Market Cap
$34.2B
Pitch Price
$78.18
Price Target
29.00 (-70%)
Dividend
N/A
EV/EBITDA
10.35
P/E
48.27
EV/Sales
2.92
Sector
Pharmaceuticals
Category
growth
Teva: The Pivot to Growth delivers 11th consecutive quarter of growth ($TEVA)
TEVA: 'Pivot to Growth' showing results - 11 consecutive quarters growth, innovative portfolio >20% revenue. AUSTEDO >$2.5B by 2027, UZEDY+olanzapine LAI $1.5-2B peak. 55.3% gross margin, targeting 30% op margin by 2027. 8 Strong Buy ratings, $28-29 price target vs current levels.
Read full article (3 min)